PhRMA pres warns against DTC moratorium

Share this article:
In a statement warning the Senate against imposing a moratorium on DTC, PhRMA president and CEO Billy Tauzin said: “DTC empowers patients by increasing their awareness of diseases and available treatments. Banning this information— even for just a couple of years—is not in the best interest of patients and physicians who every day make important healthcare decisions.”

Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.